Equities

Milton Essex SA

MTN:WSE

Milton Essex SA

Actions
  • Price (PLN)0.52
  • Today's Change0.01 / 1.96%
  • Shares traded15.58k
  • 1 Year change-35.00%
  • Beta--
Data delayed at least 15 minutes, as of Jun 13 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Milton Essex SA is a Poland-based company engaged in medical equipment production, research, and development. The Company works on Informational Technology (IT) systems, that could help in the medical field. The Firm cooperates with specialists of various fields- both medical and technological. The Company develops artificial intelligence (AI), that helps to detect early cancerous skin changes. The Equipment produced by the Company engages in checking the metabolism of the tested skin sample, with changed metabolism being the sign of unnatural changes. The Firm works also on an AI, that automates the reading of the skin data related to allergies. The Company tries to develop a piece of equipment for checking temperature from long distances.

  • Revenue in -- (TTM)--
  • Net income in --
  • Incorporated2016
  • Employees--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.